Table 3. Histopathological features of study subjects before and after treatment.
| Diagnosis | Before treatment n (%) | After treatment n (%) | ||||
|---|---|---|---|---|---|---|
| ENL n = 34) |
LL (n = 21) | P-value | ENL (n = 33) | LL (n = 21) | P-value | |
| Neutrophil infiltration | 20 (58.8) | 3 (14.3) | 0.004* | 5 (15.2) | 7 (33.3) | 0.058 |
| Lymphocytes | 34 (100.0) | 21 (100.0) | 0.984 | 20 (60.6) | 21 (100.0) | 0.006* |
| Foamy histiocytes | 29 (85.3) | 20 (95.3) | 0.627 | 14 (42.2) | 18 (85.7%) | 0.001* |
| Eosinophils and mast cells | 6 (17.6) | 5 (23.8) | 0.284 | 1 (3.0) | 4 (19.0) | 0.06 |
| Vasculitis | 5 (14.7) | 4 (19.0) | 0.079 | 2 (6.1) | 2 (9.5) | 0.841 |
| Necrosis | 2 (5.9) | 2 (9.5) | 0.068 | 2 (6.1) | 10 (47.6) | 0.004* |
| Panniculitis | 10 (62.5)δ | 0 (0) | <0.001* | 6(75.0%)ε | 0 (0) | 0.001* |
δ; n = 16. ε; n = 8.
* statistical test significant at P = 0.05.